Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Visentin

Showing results (121-130 of 193) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Hemasphere|October 6, 2023
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University HospitalNicolò Danesin, Mariella Lo Schirico, Greta Scapinello, et al.
Hemasphere|July 11, 2020
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre StudyAndrea Visentin, Vincenzo Nasillo, Monia Marchetti, et al.
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Haematologica|May 9, 2024
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case reportFrancesca Elice, Roberta Sommaggio, Elisa Cappuzzello, et al.
Cell Death & Disease|February 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemiaGioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, et al.
Haematologica|March 2, 2019
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscapeLaura Patrussi, Nagaja Capitani, Cristina Ulivieri, et al.
Blood Advances|October 25, 2024
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?Francesco Autore, Andrea Visentin, Marina Deodato, et al.
Hematological Oncology|March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in ItalyFrancesco Autore, Andrea Visentin, Candida Vitale, et al.
British Journal of Haematology|June 12, 2026
From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohortAlessandra Giannella, Fabrizio Vianello, Simone Zoletto, et al.
Pageof 20

Showing results (121-130 of 193) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|October 15, 2020
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective studyGessica Marchesini, Gianpaolo Nadali, Davide Facchinelli, et al.
Hemasphere|October 6, 2023
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University HospitalNicolò Danesin, Mariella Lo Schirico, Greta Scapinello, et al.
Hemasphere|July 11, 2020
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre StudyAndrea Visentin, Vincenzo Nasillo, Monia Marchetti, et al.
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Haematologica|May 9, 2024
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case reportFrancesca Elice, Roberta Sommaggio, Elisa Cappuzzello, et al.
Cell Death & Disease|February 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemiaGioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, et al.
Haematologica|March 2, 2019
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscapeLaura Patrussi, Nagaja Capitani, Cristina Ulivieri, et al.
Blood Advances|October 25, 2024
COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?Francesco Autore, Andrea Visentin, Marina Deodato, et al.
Hematological Oncology|March 4, 2026
Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in ItalyFrancesco Autore, Andrea Visentin, Candida Vitale, et al.
British Journal of Haematology|June 12, 2026
From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohortAlessandra Giannella, Fabrizio Vianello, Simone Zoletto, et al.
Pageof 20